Medtronic (MDT) Announces FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis

Go back to Medtronic (MDT) Announces FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis
Medtronic Inc. (NYSE: MDT) Delayed: 94.17 --0 (-0%)
Previous Close $94.17    52 Week High $89.27 
Open $94.17    52 Week Low $71.03 
Day High $94.17    P/E 26.75 
Day Low $94.17    EPS $3.52 
Volume 2,386